Mercado global de comprimidos de hipurato de metenamina – Tendências do setor e previsão para 2030

Análise e tamanho do mercado de comprimidos de hipurato de metenamina

Como a incidência de infecções do tracto urinário está a crescer globalmente, com casos relatados de 50-60% em mulheres adultas, a procura de comprimidos de hipurato de metenamina e, portanto, prevê-se que proporcione ao mercado um enorme crescimento. Além disso, o crescente apoio governamental ao desenvolvimento de APIs e o aumento do investimento nas indústrias farmacêuticas também expandem o crescimento do mercado.

A Data Bridge Market Research analisa uma taxa de crescimento no mercado de comprimidos de hipurato de metenamina no período de previsão 2023-2030. O CAGR esperado do mercado de comprimidos de hipurato de metenamina tende a rondar os 6,50% no período de previsão mencionado. O mercado foi avaliado em 8,9 mil milhões de dólares em 2022 e cresceria para 14,73 mil milhões de dólares até 2030. Além dos insights de mercado, como o valor de mercado, taxa de crescimento, segmentos de mercado, cobertura geográfica, participantes no mercado e cenário de mercado, o relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge também inclui análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Âmbito e segmentação do mercado de comprimidos de hipurato de metenamina

Definição de mercado

Methenamine hippurate tablets are the type of antiseptic drugs which is indicated for urinary tract infections. Methenamine hippurate tablets are manufactured by mixing some other compounds, including povidone, magnesium stearate, and saccharin sodium. This tablet has been reported to get readily absorbed by the gastrointestinal tract and thus effectively distributed in the body fluid. A single dose of methenamine hippurate tablets has been recorded to show antibacterial activity after half an hour of single 1g dose administration. From the overall tablet methenamine moiety excreted out with urine however the hippurate

Methenamine Hippurate Tablets Market Dynamics

Drivers

• Availability of Different Dosage Forms

The extensive availability of different dosage forms are enhancing the growth of the market. 20 Tablets/Bottle is a type of Hydroxycut, which contains a mixture of Amide and Carboxylic Acid salts. It is soluble in water and ethanol. Then there is another form called 60 Tablets/Bottle, a form of methenamine hippurate. It is used to treat horses having chronic diarrhea and is as an anti-carrhythmic drug in humans. It is a very effective anti-carrhythmic drug available today it contains approximately 1 mg of the active ingredient. Then , a bottle is a type of container with a neck that is narrower than the body. Bottles are often made of glass, plastic, and ceramic. Thus, all these different availability is boosting the growth of the market.

Opportunities

• Rising Cases of Urinary Tract Infections

Community-associated UTI (CAUTI) incidence is 0.7% and the primary risk factors are age, history of UTI, sexual activity and diabetes. Globally, around 150 million individuals develop UTIs. The highest incidence of symptomatic infections is prevalent in young, sexually active women aged 18 to 24 years, with one-third to one-half of women reported having at least one UTI by age 32. In the U.S., 70–80% of complicated UTIs are attributable to catheters, resulting in 1 million cases per year. Thus, this boosts the market growth.

 Restraints/Challenges

• Severe Effects of Methenamine Hippurate Tablets

The common symptoms associated with methenamine hippurate tablets are nausea, diarrhea, abdominal cramps, vomiting, and loss of appetite. If any of these effects continue or get worsen, immediate consultation is necessary. Painful or difficult urination may occur with methenamine, although less often.

This methenamine hippurate tablets market market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the methenamine hippurate tablets market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Global Methenamine Hippurate Tablets Market Scope

The methenamine hippurate tablets market is segmented on the basis of type, application, population type, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• 20 Tablets/Bottle
• 6 Tablets/ Bottle

Application

• Uncomplicated UTIs
• Healthcare-associated UTIs

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Methenamine Hippurate Tablets Market Regional Analysis/Insights

The methenamine hippurate tablets market is analyzed and market size insights and trends are provided by type, application, end user, distribution channel as referenced above.

The major countries covered in the methenamine hippurate tablets market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Europe has been witnessing the highest growth for the methenamine hippurate tablets market throughout the forecasted period because of the constant rise in the chronic infections among women and growing cases of postmenopausal UTIs.

North America dominates the market because of the growing disposable income and increasing cases of urological procedures. Furthermore, Europe accounts the second largest market share because of the rising awareness for urinary tract infections and wide presence of distribution network for methenamine hippurate tablets.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Cenário competitivo e análise global da quota de mercado dos comprimidos de hipurato de metenamina

O panorama competitivo do mercado de comprimidos de hipurato de metenamina fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de comprimidos de hipurato de metenamina.

Os principais players que trabalham no mercado dos comprimidos de hipurato de metenamina incluem:

• Validus Pharmaceuticals LLC (EUA)
• Alvogen (EUA)
• Micro Labs USA, Inc. (Índia)
• Aurobindo Pharma EUA. (NÓS)
• Edenbridge Pharmaceuticals, LLC (EUA)
• Kreative Organics (Índia)
• Viatris Inc (EUA)
• CorePharma LLC (EUA)

SKU-59068